Who owns VIGIL NEUROSCIENCE?
- Ticker: VIGL
- CUSIP Number: 92673k108
Tip: Access positions for across all investors
Analyze quarterly positions in Vigil Neuroscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vigil Neuroscience stock
Who bought or sold VIGIL NEUROSCIENCE this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors | 5.8M | $20M | 0% | Mar 2024 |
|
| Northpond Ventures | 4.2M | $14M | 0% | Mar 2024 |
|
| Citadel Advisors | 2.2M | $7.4M | 0% | Mar 2024 |
|
| BVF | 1.8M | $6.2M | 0% | Mar 2024 |
|
| Artal Group | 1.8M | $6.2M | 0% | Mar 2024 |
|
| Sphera Funds Management | 1.7M | $5.9M | 223% | Mar 2024 |
|
| 683 Capital Management | 995k | $3.4M | 100% | Mar 2024 |
|
| Deerfield Management Company | 980k | $3.3M | -16% | Mar 2024 |
|
| Vanguard Group | 895k | $3.1M | 12% | Mar 2024 |
|
| BlackRock | 877k | $3.0M | 4% | Mar 2024 |
|
| Rock Springs Capital Management | 472k | $1.6M | 0% | Mar 2024 |
|
| OrbiMed Advisors | 449k | $1.5M | 0% | Mar 2024 |
|
| Geode Capital Management | 334k | $1.1M | 10% | Mar 2024 |
|
| Arrowpoint Asset Management | 290k | $987k | 0% | Mar 2024 |
|
| Ensign Peak Advisors | 229k | $780k | 1818% | Mar 2024 |
|
| Northern Trust | 139k | $473k | 10% | Mar 2024 |
|
| Barclays | 113k | $386k | -9% | Mar 2024 |
|
| DAFNA Capital Management | 72k | $245k | 0% | Mar 2024 |
|
| Citigroup | 67k | $224k | 1% | Mar 2024 |
|
| Bridgeway Capital Management | 58k | $198k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 46k | $156k | -6% | Mar 2024 |
|
| Two Sigma Investments | 45k | $153k | 186% | Mar 2024 |
|
| Charles Schwab Investment Management | 42k | $143k | 0% | Mar 2024 |
|
| Bank Of Montreal | 33k | $235k | 100% | Mar 2024 |
|
| Millennium Management | 33k | $113k | 100% | Mar 2024 |
|
| Nuveen Asset Management | 27k | $92k | 9% | Mar 2024 |
|
| Two Sigma Advisers | 24k | $82k | 100% | Mar 2024 |
|
| Morgan Stanley | 23k | $80k | 89% | Mar 2024 |
|
| Springbok Capital Management | 20k | $70k | 100% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 19k | $65k | 100% | Mar 2024 |
|
| Bank of America Corporation | 19k | $65k | -35% | Mar 2024 |
|
| Goldman Sachs Group | 18k | $62k | -79% | Mar 2024 |
|
| Rhumbline Advisers | 18k | $61k | 4% | Mar 2024 |
|
| UBS Group | 16k | $55k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 10k | $35k | 0% | Mar 2024 |
|
| American International | 8.0k | $27k | 0% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 7.7k | $26k | -6% | Mar 2024 |
|
| Jpmorgan Chase & Co | 7.1k | $24k | -32% | Mar 2024 |
|
| Tower Research Capital | 5.8k | $20k | 146% | Mar 2024 |
|
| Wells Fargo & Company | 5.7k | $19k | 15% | Mar 2024 |
|
| FMR | 1.7k | $5.6k | -99% | Mar 2024 |
|
| Legal & General Group | 1.6k | $5.3k | 0% | Mar 2024 |
|
| Summit Investment Advisors | 1.3k | $4.5k | 0% | Mar 2024 |
|
| Amalgamated Bank | 542.00 | $2.0k | -61% | Mar 2024 |
|
| Royal Bank of Canada | 367.00 | $0 | -91% | Mar 2024 |
|
| Capital Advisors | 4.00 | $0 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 2.00 | $6.000000 | 100% | Mar 2024 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Vigil Neuroscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Dec 2023 | 10k | $34k |
| California State Teachers Retirement System | Sep 2023 | 3.5k | $19k |
| Coppell Advisory Solutions | Sep 2023 | 34.00 | $5.2k |